FDA Import Refusal 799-4576076-6/21/1 — Glaxo Smithkline Pakistan Limited
The FDA refused shipment 799-4576076-6/21/1 from Glaxo Smithkline Pakistan Limited (Pakistan) on Sep 15, 2021. The refused product falls under Drugs and Biologics — DEXCHLORPHENIRAMINE MALEATE (ANTI-HISTAMINIC). Cited charges: 118,3280 This firm has 1 other import refusal on record.
Refusal details
- Date
- Sep 15, 2021
- Country
- Pakistan
- Product Category
- Drugs and Biologics
- Product Code
- 61XCY16 DEXCHLORPHENIRAMINE MALEATE (ANTI-HISTAMINIC)
- Charges
- 118,3280